66例胎儿生长受限患者围产结局分析  

The analysis of perinatal outcomes for 66 cases with fetal growth restriction

作　　者：郑云 王小青[1] 孙雪松 ZHENG Yun;WANG Xiaoqing;SUN Xuesong(The Third People′s Hospital of Datong,Datong 037008,China)

机构地区：[1]大同市第三人民医院,山西大同037008

出　　处：《临床医药实践》2022年第6期437-440,共4页Proceeding of Clinical Medicine

摘　　要：目的:探讨入院孕28~34周的胎儿生长受限患者最终的围产结局。方法:选择2015年1月1日—2020年12月31日在大同市第三人民医院产科收治的孕28~34周的符合研究条件的单胎儿生长受限孕妇66例,分为对照组(患者及家属选择期待治疗者34例)和分娩组(促胎肺治疗后适时结束妊娠者32例)。治疗主要采取针对病因治疗、增加营养、硫酸镁脑保护、低分子肝素抗凝等方案。比较两样本的超声监测情况、围产结局等指标。结果:两组入院孕周、终止妊娠孕周、新生儿出生体质量及母体并发症比较差异均有统计学意义(P<0.05)。两组新生儿窒息、围产儿病死率、剖宫产率、产后出血率、不良事件发生率比较差异无统计学意义。结论:28~34周胎儿生长受限母体并发症是选择尽快分娩的主要原因。对于母儿情况相对稳定者,期待治疗可延长孕周,提高新生儿体质量,但是否选择期待治疗对母儿主要围产结局影响不大。Objective:To investigate the perinatal outcomes in pregnant women with singleton fetal growth restriction admitted to hospital at 28~34 weeks of gestation.Methods:All 66 cases with singleton fetal growth restriction at 28~34 weeks who were admitted to the department of obstetrics of the third people′s hospital of datong city from January 1,2015 to December 31 in 2020.They were divided into control group(control group)and delivery group(delivery group)after related treatments such as promoting fetal lung maturation.The treatment was mainly etiology specific,nutrition support,magnesium sulfate cerebral protection,and low molecular heparin anticoagulation,et al.There are 34 cases in the expectant treatment group and 32 cases in the delivery group.To compare ultrasound monitoring and perinatal outcomes between the two samples.Results:There were significant differences in the gestational weeks at admission,gestational weeks at termination of pregnancy,birth weight of newborns and the comparison of complications between the two groups(P<0.05).There was no significant difference in neonatal asphyxia and perinatal mortality between the two groups,and there was no significant difference in the cesarean section rate,postpartum hemorrhage rate,and adverse events between the two groups.Conclusion:The maternal complication were the main causes for treat choice of the fetal growth restriction at 28~34 weeks.Expectant treatment can prolong the gestational week,improves neonatal weight.Whether expectant therapy can not impact the main perinatal outcome.

关 键 词：胎儿生长受限 母体并发症 低分子肝素 期待治疗 围产结局 

分 类 号：R722[医药卫生—儿科]